PHOENIX--(BUSINESS WIRE)--Zila, Inc. (NASDAQ:ZILA) today announced that it will begin its global expansion initiative with the distribution of ViziLite® Plus with TBlue630™ in Canada. The product will be launched at the Toronto Academy of Dentistry Winter Meeting on November 9, 2007. “Today marks an important milestone for the organization, as we take the first step in our plan to make ViziLite Plus available throughout the world,” stated Dr. Frank J. Bellizzi, President of Zila Pharmaceuticals. “Oral cancer is a global problem, as evidenced by it being the 6th leading cause of cancer deaths worldwide – over 90% of the 400,000 reported cases annually occur outside the United States.”
